PI
TLSIW icon

PEAK6 Investments’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

PEAK6 Investments’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,308
Closed -$245K – 5791
2021
Q2 		$245K Buy
25,308
+16,976
+204% +$16.8K ﹤0.01% 3860
2021
Q1 		$9K Buy
+8,332
New +$15K ﹤0.01% 4678

Other funds holding TLSIW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

PEAK6 Investments's TLSIW Position: Q3 2021 in Review

PEAK6 Investments sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2021, closing a stake of 25,308 shares — an estimated $245K sold.

PEAK6 Investments first reported a position in TLSIW in Q1 2021 and held it in 2 quarters. The position peaked at $245K in Q2 2021. 25 funds tracked by Wall St. Rank hold TLSIW as of Q3 2021.

  • PEAK6 Investments reported no remaining TriSalus Life Sciences Warrant position as of Q3 2021 after selling out during the quarter.
  • PEAK6 Investments sold 25,308 TriSalus Life Sciences Warrant shares in Q3 2021, an estimated $245K.
  • PEAK6 Investments first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 2 quarters.
  • PEAK6 Investments's TriSalus Life Sciences Warrant position peaked at $245K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2021.

Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.